Dezhan Healthcare Company Limited (SHE:000813)
China
· Delayed Price · Currency is CNY 3.620
0.00 (0.00%)
Mar 10, 2026, 3:04 PM CST
Dezhan Healthcare Company Revenue
Dezhan Healthcare Company had revenue of 111.14M CNY in the quarter ending September 30, 2025, with 4.70% growth. This brings the company's revenue in the last twelve months to 389.51M, down -24.72% year-over-year. In the year 2024, Dezhan Healthcare Company had annual revenue of 466.49M, down -6.34%.
Revenue (ttm)
389.51M
Revenue Growth
-24.72%
P/S Ratio
19.49
Revenue / Employee
369.56K
Employees
1,054
Market Cap
7.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 466.49M | -31.60M | -6.34% |
| Dec 31, 2023 | 498.09M | -72.77M | -12.75% |
| Jan 1, 2023 | 570.86M | -163.62M | -22.28% |
| Jan 1, 2022 | 734.48M | -228.39M | -23.72% |
| Dec 31, 2020 | 962.87M | -812.10M | -45.75% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cisen Pharmaceutical | 3.56B |
| Sichuan Huiyu Pharmaceutical | 998.15M |
| Shandong Wit Dyne Health | 2.36B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Frontier Biotechnologies | 143.67M |
| Changchun BCHT Biotechnology Co. | 591.81M |
| Hainan Haiyao | 825.66M |
| Northeast Pharmaceutical Group | 6.85B |